MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.
1 report, 1 independent
Updated Sep 16
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MDR/IVDR reforms require adoption by the European Parliament, referencing US FDA pre-submission meetings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Commission
executive branch of the European Union
-
European Parliament
parliament of the European Union directly elected by the citizens of the Union
- FDA
Related events
- Both the FDA and the European Medicines Agency govern drug approval processes.
- A 2019 finding indicated that the US regulatory process was slower than European standards.
- Congress considered proposals to strengthen FDA authority regarding medical device regulation and minimum standards.
- The FDA and European Medicines Agency are harmonizing regulatory review of drug applications.
- FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.